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Introduction
Dobutamine cardiovascular magnetic resonance (DCMR)
can identify individuals with a poor cardiac prognosis
when they have a normal resting left ventricular (LV) ejec-
tion fraction (LVEF).
Purpose
We sought to determine the predictive value of DCMR
results for predicting cardiac events in individuals with a
moderately to severely reduced resting LVEF.
Methods
Two-hundred consecutively referred patients aged 64 ± 11
years with a LVEF ≤ 55% that were poorly suited for stress
echocardiography, underwent DCMR in which rest, low
dose, peak dobutamine/atropine stress were completed.
Left ventricular wall motion score index (WMSI), defined
as the average wall motion score of 17 myocardial seg-
ments (1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dys-
kinetic scored for each segment) was assessed at all 3
stages of stress. All 200 participants were contacted again
at an average of 5 years after DCMR. The post DCMR
events of cardiac death, myocardial infarction (MI), and
unstable angina or congestive heart failure warranting
hospitalization were confirmed by review of participants'
medical records.
Results
One hundred forty subjects had a stable or increased
WMSI with dobutamine and during the follow-up period
63 (45%) experienced any cardiac event and 19 (14%)
experienced a MI or cardiac death. Sixty subjects had an
increase in WMSI during dobutamine with 43 (72%)
experienced any event, and 16 (27%) had a recorded MI
or cardiac death. After adjustment for cardiovascular risk
factors, subjects with an increase in WMSI during stress
DCMR had reduced event free survival (p < 0.001). After
accounting for resting LVEF, the hazard ratio (HR) for hav-
ing an event due to an increase in WMSI was 2.20 (p =
0.0015) for patients with a LVEF >40%. For patients with
a LVEF <40%, the HR due to either an increase in WMSI
during dobutamine or an absence of an increase in WMSI
during dobutamine, was 3.64 and 2.84, respectively.
Importantly, after accounting for a resting LVEF <40%, an
increase in WMSI during intravenous dobutamine did not
independently predict future MI and cardiac death (HR =
1.36, p = 0.36).
Conclusion
In patients with a LVEF of 40% to 55%, stress induced
changes in LV WMSI observed during DCMR predict
adverse cardiac events beyond resting LVEF. In patients
with a LVEF <40%, procedures other than observation of
from 11th Annual SCMR Scientific Sessions
Los Angeles, CA, USA. 1–3 February 2008
Published: 22 October 2008
Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):A21 doi:10.1186/1532-429X-10-S1-A21
<supplement> <title> <p>Abstracts of the 11<sup>th </sup>Annual SCMR Scientific Sessions - 2008</p> </title> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1532-429X-10-s1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1532-429X-10-S1-info.pdf</url> </supplement>
This abstract is available from: http://jcmr-online.com/content/10/S1/A21
© 2008 Dall'Armellina et al; licensee BioMed Central Ltd. Page 1 of 2
(page number not for citation purposes)
Journal of Cardiovascular Magnetic Resonance 2008, 10(Suppl 1):A21 http://jcmr-online.com/content/10/S1/A21Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
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